Daily as of 3 Nov 16:00 ET
- Price
- below both $152.17 vs 50 $161.19 / 200 $160.37
- Projection
- 💀Death cross projected in 9 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 4 Sep 2026 · projected 12 bars out
BLTE | Belite BioNASDAQADR golden cross and death cross projections, cross tests and history
$152.17
-$1.50 (-0.98%)
Belite Bio (BLTE) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2023.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2026, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $154.74 vs 50 $157.72 / 200 $75.75
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- below both $152.17 vs 50 $153.32 / 200 $157.98
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 27 Oct 2026 · projected 24 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 27 Oct 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 4 Sep 2026 | 🟨Golden moderate | daily | 12 bars out | Not tested |
| 6 Aug 2026 | 🟨Golden | 4-hour | 7 bars out | Not tested |
| 21 Jul 2026 | 💀Death flat | daily | 18 bars out | Not tested |
| 6 May 2026 | 💀Death | 4-hour | 1 bar out | Not tested |
About BLTE
ExchangeNASDAQ
InstrumentADR
Median $ volume, 60 d$25.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
Cap bandmid